Logo image of AZTA

AZENTA INC (AZTA) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:AZTA - US1143401024 - Common Stock

37.92 USD
+0.42 (+1.12%)
Last: 1/9/2026, 8:00:00 PM
37.92 USD
0 (0%)
After Hours: 1/9/2026, 8:00:00 PM

AZTA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.74B
Revenue(TTM)593.82M
Net Income(TTM)-55.76M
Shares45.86M
Float44.69M
52 Week High55.64
52 Week Low23.91
Yearly Dividend0
Dividend Yield0%
EPS(TTM)0.53
PE71.55
Fwd PE47.47
Earnings (Next)02-03 2026-02-03/amc
IPO1995-02-02
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


AZTA short term performance overview.The bars show the price performance of AZTA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20 25

AZTA long term performance overview.The bars show the price performance of AZTA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of AZTA is 37.92 USD. In the past month the price increased by 3.89%. In the past year, price decreased by -26.65%.

AZENTA INC / AZTA Daily stock chart

AZTA Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 27.63 232.51B
DHR DANAHER CORP 30.92 168.37B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 200.78 61.01B
IQV IQVIA HOLDINGS INC 20.84 41.28B
A AGILENT TECHNOLOGIES INC 26.62 42.11B
MTD METTLER-TOLEDO INTERNATIONAL 35.5 30.34B
WAT WATERS CORP 31.24 23.62B
ILMN ILLUMINA INC 32.36 21.56B
WST WEST PHARMACEUTICAL SERVICES 38.97 19.82B
MEDP MEDPACE HOLDINGS INC 41.61 16.76B
TEM TEMPUS AI INC N/A 11.79B
RVTY REVVITY INC 21.8 11.84B

About AZTA

Company Profile

AZTA logo image Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Company Info

AZENTA INC

200 Summit Drive, 6Th Floor

Burlington MASSACHUSETTS US

Employees: 3000

AZTA Company Website

AZTA Investor Relations

Phone: 19782622400

AZENTA INC / AZTA FAQ

Can you describe the business of AZENTA INC?

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.


What is the stock price of AZENTA INC today?

The current stock price of AZTA is 37.92 USD. The price increased by 1.12% in the last trading session.


Does AZENTA INC pay dividends?

AZTA does not pay a dividend.


How is the ChartMill rating for AZENTA INC?

AZTA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Where is AZENTA INC (AZTA) stock traded?

AZTA stock is listed on the Nasdaq exchange.


What is the Price/Earnings (PE) ratio of AZENTA INC (AZTA)?

The PE ratio for AZENTA INC (AZTA) is 71.55. This is based on the reported non-GAAP earnings per share of 0.53 and the current share price of 37.92 USD.


What is the employee count for AZTA stock?

AZENTA INC (AZTA) currently has 3000 employees.


AZTA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to AZTA. When comparing the yearly performance of all stocks, AZTA is a bad performer in the overall market: 65.34% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AZTA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AZTA. AZTA has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AZTA Financial Highlights

Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.53. The EPS increased by 29.27% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2.71%
ROE -3.23%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%16.67%
Sales Q2Q%-6.39%
EPS 1Y (TTM)29.27%
Revenue 1Y (TTM)-9.52%

AZTA Forecast & Estimates

14 analysts have analysed AZTA and the average price target is 39.63 USD. This implies a price increase of 4.52% is expected in the next year compared to the current price of 37.92.

For the next year, analysts expect an EPS growth of 50.72% and a revenue growth 4.54% for AZTA


Analysts
Analysts75.71
Price Target39.63 (4.51%)
EPS Next Y50.72%
Revenue Next Year4.54%

AZTA Ownership

Ownership
Inst Owners111.91%
Ins Owners0.63%
Short Float %9.1%
Short Ratio6.22